9 Transactions with related companies and persons
9.1 Compensation paid to members of the Board of Directors and to members of the Group Executive Board
|
CHF 1 000 |
|
Fixed compensation paid in cash |
|
Short-term variable compensation paid in cash |
|
Short-term variable compensation paid in shares |
|
Long-term variable compensation paid in shares |
|
Total |
|
Total 1.1.–31.12.2022 |
|
|
|
|
|
|
|
|
|
|
|
Compensation to members of the Board of Directors |
|
613 |
|
– |
|
181 |
|
– |
|
794 |
|
Compensation to members of the Group Executive Board |
|
1 018 |
|
632 |
|
1 482 |
|
– 110 |
|
3 022 |
|
Total 1.1.–31.12.2021 |
|
|
|
|
|
|
|
|
|
|
|
Compensation to members of the Board of Directors |
|
616 |
|
– |
|
245 |
|
– |
|
861 |
|
Compensation to members of the Group Executive Board |
|
1 124 |
|
1 547 |
|
1 075 |
|
150 |
|
3 896 |
The amounts listed for fixed and variable compensation also include any employer contributions to statutory or regulatory social security schemes.
The short-term variable compensation in shares of the Board of Directors consists of the following items:
- TCHF 147 (2021: TCHF 147) in 4 years restricted shares
- TCHF 34 (2021: TCHF 98) in 3 years blocked and discounted shares from participation program (monetary benefit)
The short-term variable compensation in shares of the Group Executive Board consists of the following items:
- TCHF 283 (2021: TCHF 318) in 4 years restricted shares
- TCHF 1 136 (2021: TCHF 592) in 4 years restricted shares with one-year service period and right of redemption (taking into account the service/vesting period in accordance with IFRS 2)
- TCHF 63 (2021: TCHF 165) in 3 years blocked and discounted shares from participation program (monetary benefit)
Members of the Group Executive Board partially participate in an employee stock ownership plan in connection with the asset management mandate of BB Biotech AG. Within the scope of these plans, some of the members of the Group Executive Board are entitled to receive a maximum number of shares in BB Biotech AG. The actual number of shares awarded depends on various conditions. Awarded shares are subject to a three-year vesting period beginning on the date of grant. In addition, the actual number of shares distributed will depend on the achievement of certain performance targets over the subsequent three fiscal years in connection with the respective investment mandates. The cost of this employee program is recognized as long-term variable compensation.
In the financial years 2022 and 2021, no compensation was paid to related parties of members of the Board of Directors and Group Executive Board, nor to former members of the Board of Directors.
9.2 Transactions with related companies and persons
As of December 31, 2022 and 2021, there were neither receivables nor liabilities to related companies and persons.